Floatz logo

Therapeutic Asset Ratings

4,493 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Inno-206
ovarian seromucinous carcinoma
National Cancer Institute (NCI)P3BB (71)
Inno-206
ovarian transitional cell carcinoma
National Cancer Institute (NCI)P3BB (71)
Inno-206
undifferentiated ovarian carcinoma
National Cancer Institute (NCI)P3BB (71)
Cediranib
brain cancer
National Cancer Institute (NCI)P2BB (71)
Cediranib
Recurrent Adult Diffuse Large Cell Lymphoma
National Cancer Institute (NCI)P2BB (71)
Cediranib
Recurrent Childhood Soft Tissue Sarcoma
National Cancer Institute (NCI)P2BB (71)
Cediranib
mycosis fungoides
National Cancer Institute (NCI)P2BB (71)
Cediranib
Recurrent Prostate Carcinoma
National Cancer Institute (NCI)P2BB (71)
Cediranib
Stage IV Colon Cancer
National Cancer Institute (NCI)P2BB (71)
Cediranib
Waldenstrom macroglobulinemia
National Cancer Institute (NCI)P2BB (71)
Veliparib
Stage IV Pancreatic Cancer
National Cancer Institute (NCI)P2BB (71)
Azacitidine
angioimmunoblastic T-cell lymphoma
National Cancer Institute (NCI)P4BB (70)
CIS-DIAMMINEDICHLOROPLATINUM II
small cell lung carcinoma
National Cancer Institute (NCI)P4BB (70)
Cyclophosphamide
leukemia
National Cancer Institute (NCI)P4BB (70)
Inno-206
mantle cell lymphoma
National Cancer Institute (NCI)P4BB (70)
PREDNISONE TABLETS
mantle cell lymphoma
National Cancer Institute (NCI)P4BB (70)
(+)-VINCRISTINE
mantle cell lymphoma
National Cancer Institute (NCI)P4BB (70)
Calcium folinate pentahydrate
T-cell Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P3BB (70)
Carboplatin
fallopian tube endometrioid adenocarcinoma
National Cancer Institute (NCI)P3BB (70)
CIS-DIAMMINEDICHLOROPLATINUM II
lung adenocarcinoma
National Cancer Institute (NCI)P3BB (70)
Cytosin-Arabinosid
acute myeloid leukemia with multilineage dysplasia
National Cancer Institute (NCI)P3BB (70)
Cytosin-Arabinosid
T-cell childhood acute lymphocytic leukemia
National Cancer Institute (NCI)P3BB (70)
Dasatinib
B-cell acute lymphoblastic leukemia
National Cancer Institute (NCI)P3BB (70)
Daunorubicin
acute basophilic leukemia
National Cancer Institute (NCI)P3BB (70)
ETOPOSIDE
T-cell childhood acute lymphocytic leukemia
National Cancer Institute (NCI)P3BB (70)
Showing 101 to 125 of 4,493 assets
PreviousPage 5 of 180Next